Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased

Clin Gastroenterol Hepatol. 2011 May;9(5):449-50.e1; author reply 450-1. doi: 10.1016/j.cgh.2011.01.021. Epub 2011 Feb 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / adverse effects*
  • Inflammatory Bowel Diseases / complications*
  • Inflammatory Bowel Diseases / drug therapy
  • Male
  • Mercaptopurine / administration & dosage*
  • Mercaptopurine / adverse effects*
  • Risk Assessment
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / epidemiology*

Substances

  • Immunosuppressive Agents
  • Mercaptopurine